GoalVest Advisory’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.67K | Hold |
830
| – | – | ﹤0.01% | 309 |
|
|
2025
Q1 | $6.17K | Hold |
830
| – | – | ﹤0.01% | 283 |
|
|
2024
Q4 | $4.98K | Hold |
830
| – | – | ﹤0.01% | 302 |
|
|
2024
Q3 | $4.25K | Hold |
830
| – | – | ﹤0.01% | 344 |
|
|
2024
Q2 | $3.01K | Hold |
830
| – | – | ﹤0.01% | 295 |
|
|
2024
Q1 | $2.66K | Hold |
830
| – | – | ﹤0.01% | 360 |
|
|
2023
Q4 | $4.07K | Hold |
830
| – | – | ﹤0.01% | 296 |
|
|
2023
Q3 | $4.52K | Hold |
830
| – | – | ﹤0.01% | 353 |
|
|
2023
Q2 | $5.57K | Hold |
830
| – | – | ﹤0.01% | 293 |
|
|
2023
Q1 | $7.33K | Hold |
830
| – | – | ﹤0.01% | 195 |
|
|
2022
Q4 | $6.34K | Hold |
830
| – | – | ﹤0.01% | 197 |
|
|
2022
Q3 | $6K | Hold |
830
| – | – | ﹤0.01% | 202 |
|
|
2022
Q2 | $8K | Hold |
830
| – | – | 0.01% | 256 |
|
|
2022
Q1 | $12K | Buy |
+830
| New | +$12K | 0.01% | 226 |
|
|
2021
Q2 | $34K | Buy |
+830
| New | +$34K | 0.02% | 160 |
|